| Lucia Gomez-elegido, | |
|
1415 E Kincaid St, Mount Vernon, WA 98274-4126 | |
| (360) 814-2697 | |
| Not Available |
| Full Name | Lucia Gomez-elegido |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1415 E Kincaid St, Mount Vernon, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699465831 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lucia Gomez-elegido, 901 20th St Apt 1, Bellingham, WA 98225-6755 Ph: (206) 779-3641 | Lucia Gomez-elegido, 1415 E Kincaid St, Mount Vernon, WA 98274-4126 Ph: (360) 814-2697 |
News Archive
The two major procedures for opening blocked neck arteries to restore blood flow to the brain proved similar in overall long-term safety and efficacy, but showed differences in stroke and heart attack in the weeks following the procedure, according to late-breaking science presented at the American Stroke Association's International Stroke Conference 2010.
A new study has found that while the cost of fresh food is becoming more and more expensive junk food is becoming cheaper.
Scancell Holdings Plc, the developer of therapeutic cancer vaccines, today announces a strategic collaboration with ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc.. Under the agreement, Scancell and ImmuneRegen will work together to investigate the synergy between ImmuneRegen's Homspera® and Scancell's ImmunoBody® vaccine technologies.
More than a cause of a simple infection, viruses are often involved in the development of serious diseases. Such is the case with liver cancer, which often develops in an organ that has been weakened by hepatitis B or C virus.
Updated data from the ongoing AURA study of AZD9291 shows encouraging, although still immature, median progression free survival of 9.6 months (95% CI 8.3 to NC) in patients with epidermal growth factor receptor mutation positive (EGFRm) T790M+ advanced non-small cell lung cancer (NSCLC) who had disease progression following treatment with an EGFR tyrosine kinase inhibitor (EGFR TKI).
› Verified 1 days ago
Ms. Susan M Bengtson, MACCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 920 S 2nd St, Mount Vernon, WA 98273 Phone: 360-428-6141 | |
Alexandra Elizabeth Jordan, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 S 18th St, Mount Vernon, WA 98274 Phone: 360-424-1320 | |
Peggy Glass Paxton, MA CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 920 S 2nd St, Mount Vernon, WA 98273 Phone: 360-428-6141 | |
Crystal Conway, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 124 E Lawrence St, Mount Vernon, WA 98273 Phone: 360-428-6110 | |
Miss Sharlet Lee Jensen, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 320 Pacific Pl, Mount Vernon, WA 98273 Phone: 360-416-7570 Fax: 360-416-7580 | |
Samantha Kerry Lundell, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 S 18th St, Mount Vernon, WA 98274 Phone: 360-424-1320 | |
Ms. Melissa Colleen Murphy, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 320 Pacific Pl, Mount Vernon, WA 98273 Phone: 360-416-7570 |